GlassScriptPhysician profile
Emily Perrotto
NPI 1376134288
$9,928.30
in general payments reported to CMS, 2019-2025
59 companies · $1,810 in 2025
The $1,810 reported for 2025 was more than what 91% of Psychiatric/Mental Health (Nurse Practitioner) providers received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $531 · 2022: $1,752 · 2023: $2,840 · 2024: $2,994 · 2025: $1,810.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,645.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,644.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,250.28 | 2021-2025 | |
| Alkermes, INC. | $798.56 | 2022-2025 | Aristada, Lybalvi |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $554.94 | 2022-2025 | Caplyta |
| Otsuka America Pharmaceutical, INC. | $519.34 | 2021-2025 | Rexulti, Nuedexta, Abilify Maintena |
| Vanda Pharmaceuticals INC. | $463.17 | 2022-2025 | Fanapt, Hetlioz |
| Neurocrine Biosciences, INC. | $452.44 | 2022-2025 | Ingrezza, Ongentys |
| Axsome Therapeutics, INC. | $420.96 | 2023-2025 | Auvelity, Sunosi |
| Lilly USA, LLC | $322.75 | 2021-2024 | Emgality, Amyvid |
| Pfizer INC. | $318.55 | 2023-2025 | |
| Biogen, INC. | $313.18 | 2022-2025 | Vumerity, Plegridy, Avonex |
| Teva Pharmaceuticals USA, INC. | $263.64 | 2023-2024 | Austedo Xr, Austedo |
| Eisai INC. | $258.54 | 2022-2025 | |
| Tg Therapeutics, INC. | $251.16 | 2023-2025 | |
| Lundbeck LLC | $245.50 | 2023-2025 | Vyepti, Rexulti |
| Emd Serono, INC. | $210.28 | 2023-2025 | Mavenclad |
Show all 59 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emily Perrotto listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.